Core Points - CARBIOS and Wankai New Materials have signed an agreement to collaborate on deploying CARBIOS' PET enzymatic recycling technology in Asia, marking a significant step in the development of a circular PET industry in the region [1][6][8] Group 1: Agreement Details - The agreement establishes a long-term commitment to build and operate several PET biorecycling plants in Asia, targeting a total capacity of one million tonnes per year [2][8] - The first joint venture will focus on constructing a PET biorecycling plant in China with an annual processing capacity of 50,000 tonnes of PET waste [3][8] - Wankai will be the main shareholder of the joint venture, which will be financed by Wankai, and is expected to start construction in the first quarter of 2026 [4][8] Group 2: Financial Aspects - Wankai will invest €5 million in CARBIOS S.A. to strengthen the strategic partnership [4] - The finalization of the partnership, including the shareholders' agreement and license agreement, is expected by the end of 2025 [5][8] Group 3: Strategic Importance - China, as the world's leading producer of PET, is a crucial market for CARBIOS, and this agreement is seen as a strategic advancement for both companies [6][8] - The collaboration aims to accelerate the transition to a more circular and low-carbon PET industry [7][8]

Core Points - CARBIOS and Wankai New Materials have signed a fundamental agreement to collaborate on deploying CARBIOS' enzymatic PET recycling technology in Asia [1][2] - The partnership aims to build and operate multiple biorecycling plants in Asia with a target capacity of 1 million tons per year [2][9] - The first step involves creating a joint venture to construct and operate a biorecycling plant in China with an annual capacity of 50,000 tons of PET waste [3][9] Company Overview - CARBIOS is a biotechnology company focused on developing biological solutions to reinvent the lifecycle of plastics and textiles, utilizing enzyme-based processes for plastic deconstruction [8] - The company has been operational since 2021 with its industrial demonstration plant for biorecycling and plans to commence construction of the world's first biorecycling plant by the end of 2025, pending additional funding [8] - CARBIOS is supported by prestigious brands in the cosmetic, food, and apparel industries to enhance the recyclability and circularity of their products [8][10] Investment and Financial Aspects - Wankai will be the majority shareholder of the joint venture and will guarantee the financing for the first biorecycling plant, with an investment of €5 million in CARBIOS' capital [4][5] - The partnership remains subject to the finalization of definitive agreements, including a shareholders' pact and a licensing contract, with the goal of signing by the end of the year [5][9] Strategic Importance - The agreement marks a strategic step for both CARBIOS and Wankai, aiming to accelerate the development of a circular PET industry in Asia, which is a key market for CARBIOS as the world's largest PET producer [6][7] - This collaboration is seen as a significant milestone in the international deployment of CARBIOS' technology and its licensing model [7]

Group 1 - CARBIOS has released its Interim report for the first half of 2025, which is available for shareholders and the financial community [1] - The company focuses on developing and industrializing biological technologies aimed at reinventing the lifecycle of plastics and textiles [2] - CARBIOS has two main technologies: PET biorecycling and PLA biodegradation, which are currently being scaled up to industrial and commercial levels [2] Group 2 - The industrial demonstration plant for biorecycling has been operational since 2021, with the construction of the world's first biorecycling plant expected to resume before the end of 2025, pending additional funding [2] - CARBIOS collaborates with major brands in the cosmetics, food, and apparel industries to enhance the recyclability and circularity of their products [2] - The company is part of the global community of B Corp™ certified companies, indicating a commitment to transforming business models for the common good [2]

Financial Results - The company reported a solid cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 months, thanks to a cost-saving plan executed in the first half of 2025 [2][6] - Revenue for the first half of 2025 was €519,000, compared to €73,000 in the same period of 2024, indicating significant growth [12][27] - The current operating loss improved to €17.6 million from €20 million year-over-year, attributed to reduced operating expenses and increased revenues [14][15] Regulatory Environment Developments - A new decree in France provides financial incentives for incorporating recycled materials into products, offering a €1,000/ton bonus for using biorecycled plastics in sensitive-contact packaging [3][9] - This regulatory change is expected to accelerate customer adoption of CARBIOS' technology, allowing the company to supply high-quality recycled PET (r-PET) at a competitive price [3][9] Longlaville PET Biorecycling Plant Update - The construction of the Longlaville biorecycling plant is expected to resume before the end of 2025, contingent upon securing additional funding [6][9] - The plant is set to be commissioned in the second half of 2027, with significant progress made in securing public funding and interest from private investors [6][9][13] - Pre-sales of products from the future plant are progressing, supported by a favorable regulatory environment [7][9] Licensing and Technological Development - The company remains committed to the commercialization of licenses for its technology, supported by technological maturity and ongoing negotiations with various partners [10] - CARBIOS has secured a significant portion of its raw material supply and signed polymerization contracts, strengthening the project's industrial foundations [7][10] Cash Flow and Financial Position - The net cash consumption for the first half of 2025 was €18.1 million, a decrease from €102.1 million in 2024, reflecting improved cash management [19][30] - Cash and cash equivalents at the end of the period stood at €71.7 million, down from €89.8 million at the beginning of the period [19][30]